Tune Therapeutics

Durham, NC · Founded 2020 · Privately Held (backing)

Developer of an epigenetic programming platform designed to create new pathways for the treatment of disease. Tune Therapeutics is based in Durham, NC and was founded in 2020. Its last reported valuation was $340 million in Jan 2025. It has raised $222 million.

Last reported valuation
$340.0M
Oct 2026
Priced at
—
Total raised
$222.4M
Last round
—

Who backs Tune Therapeutics?

15 investors
InvestorType
New Enterprise AssociatesVenture capital
Emerson CollectiveOther
Duke Capital PartnersVenture capital
Hatteras Venture PartnersVenture capital
Mission BioCapitalVenture capital
WRF CapitalOther
Alexandria Real Estate Equities—
Biovision Ventures—
Cornell University—
Hevolution Foundation—
+ 5 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Tune Therapeutics investors

15 investors are on record for Tune Therapeutics, including New Enterprise Associates, Emerson Collective, Duke Capital Partners and Hatteras Venture Partners.

Free account
More of Tune Therapeutics with a free account
  • ·The complete investor list: 15 names
  • ·Watch Tune Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 15 firms already write checks for companies like Tune Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View